Search

Voyager Therapeutics Inc

Slēgts

3.68

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.55

Max

3.82

Galvenie mērījumi

By Trading Economics

Ienākumi

-511K

-28M

Pārdošana

-13M

2.6M

EPS

-0.47

Peļņas marža

-1,077.401

Darbinieki

141

EBITDA

1.9M

-27M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+349.74% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-16M

219M

Iepriekšējā atvēršanas cena

3.68

Iepriekšējā slēgšanas cena

3.68

Voyager Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 7. jūl. 23:56 UTC

Macro News
ETF Constituents
Correlated Moves
Social Media

Financial Select Sector SPDR Fund declines in after-market trading amid escalating Middle East tensions and concerns over oil supply routes affecting inflation and Fed policy.

2026. g. 7. jūl. 23:56 UTC

Correlated Moves

NXP Semiconductors NV shares are lower in after-market hours, following a decline in the Nasdaq 100 Index and amid ongoing geopolitical tensions.

2026. g. 7. jūl. 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF showed minimal movement in after-market hours, reflecting broader market trends amid concerns over valuations and geopolitical tensions.

2026. g. 7. jūl. 23:56 UTC

Macro News
ETF Constituents
Correlated Moves

ROBO shares advanced in after-market hours, supported by gains from top holdings IPGP and ISRG amid rising crude oil prices and geopolitical tensions.

2026. g. 7. jūl. 23:56 UTC

Macro News
Correlated Moves

The US 30Y Treasury Bond Index is trading lower amid heightened geopolitical tensions following U.S. military strikes against Iran and rising crude oil prices.

2026. g. 7. jūl. 23:56 UTC

Macro News
ETF Constituents

Health Care Select Sector SPDR Fund trades higher after-market, supported by gains in LLY, MDT, and JNJ, despite rising crude oil prices and broader market pressures.

2026. g. 7. jūl. 23:52 UTC

Global equity markets decline amid rising geopolitical tensions, tech stock pullbacks, and widening U.S. trade deficit.

2026. g. 7. jūl. 23:52 UTC

Asia equity markets mixed as Nikkei and Hang Seng decline amid AI boom concerns and geopolitical tensions, while U.S. Treasury yields rise on increased volatility.

2026. g. 7. jūl. 23:52 UTC

European equity markets show mixed results amid geopolitical tensions, with Germany's DAX down 1.3% despite stronger industrial production, while France's trade deficit widens and the euro weakens against the dollar.

2026. g. 7. jūl. 23:52 UTC

U.S. equity indices decline amid widening trade deficit and geopolitical tensions, with tech stocks particularly affected.

2026. g. 7. jūl. 23:51 UTC

Correlated Moves

The SGD/CHF has advanced during Tuesday's session, reflecting a steady increase since Monday's close, supported by a rise in USD/CHF.

2026. g. 7. jūl. 23:51 UTC

Social Media
Correlated Moves

Intuit Inc. shares fell in after-market trading, mirroring a decline in the Nasdaq 100 Index. The stock's price-to-earnings ratio is 17 times earnings.

2026. g. 7. jūl. 23:51 UTC

Microchip Technology Inc shares are higher in after-market hours, reflecting a modest gain since Tuesday's close amid routine trading activity.

2026. g. 7. jūl. 23:51 UTC

Brazil's Central Bank to announce interest rate decision on July 13, 2026, amid cautious sentiment over inflation and economic growth.

2026. g. 7. jūl. 23:51 UTC

Japan's Machinery Orders Data Release on July 14 Expected to Reflect Recovery Amid Mixed Economic Sentiment and Rising Household Spending.

2026. g. 7. jūl. 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

2026. g. 7. jūl. 23:51 UTC

American Airlines Group shares declined in after-market trading, continuing a trend of lower daily closes amid a widening U.S. trade deficit.

2026. g. 7. jūl. 23:51 UTC

Correlated Moves

The USD/CZK is higher today, reflecting a modest increase since Monday's close, amid broader gains in correlated assets like the USD/CHF.

2026. g. 7. jūl. 23:51 UTC

JD.Com Inc shares are trading higher in after-market hours, though no specific news has been identified to explain the movement.

2026. g. 7. jūl. 23:51 UTC

Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a broader market downturn and ongoing geopolitical tensions. The stock has declined for four consecutive sessions.

2026. g. 7. jūl. 23:51 UTC

Correlated Moves

KLA Corp shares are lower in after-market trading, influenced by a widening U.S. trade deficit of $77.6 billion and rising interest rate concerns.

2026. g. 7. jūl. 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and ongoing economic concerns, including a widening U.S. trade deficit.

2026. g. 7. jūl. 23:51 UTC

Social Media
Correlated Moves

Western Digital Corp shares declined in after-market trading, reflecting broader market trends as the Nasdaq 100 Index also fell. The asset remains below its 20-day moving average.

2026. g. 7. jūl. 23:46 UTC

eBay Inc shares are lower in after-market hours amid no specific news. The U.S. trade deficit widened in May, impacting market sentiment.

2026. g. 7. jūl. 23:46 UTC

Macro News
ETF Constituents

Crude oil prices rose amid U.S.-Iran tensions, potentially impacting biotechnology costs. iShares Biotechnology ETF traded near unchanged during after-market hours.

2026. g. 7. jūl. 23:46 UTC

Macro News
ETF Constituents

COPX is higher in after-market hours, supported by strong performances from Freeport-McMoRan and Southern Copper amid rising crude oil prices and geopolitical tensions.

2026. g. 7. jūl. 23:46 UTC

Trip.com Group Ltd shares declined in after-market trading, pulling back from a session high and remaining below their 20-day moving average.

2026. g. 7. jūl. 23:46 UTC

Lululemon Athletica Inc shares are lower in after-market hours amid broader concerns over the U.S. trade deficit, which widened to $77.6 billion in May.

2026. g. 7. jūl. 23:46 UTC

Terra is trading higher during Tuesday's session, despite pulling back from earlier highs. It remains above its 20-day moving average.

2026. g. 7. jūl. 23:46 UTC

ETF Constituents
Macro News
Correlated Moves

The iShares MSCI South Korea ETF is lower in after-market hours, influenced by rising crude oil prices and declines in major indices.

Salīdzinājums

Cenas izmaiņa

Voyager Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

349.74% augšup

Prognoze 12 mēnešiem

Vidējais 17 USD  349.74%

Augstākais 25 USD

Zemākais 8 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Voyager Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

6

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
help-icon Live chat